ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Durata Therapeutics, Inc. 

89 Headquarters Plaza North
Suite 306
Morristown  New Jersey  07960  U.S.A.
Phone: 646-871-6480 Fax: 973-993-4865


SEARCH JOBS


Industry
Biotechnology






 Company News
FDA Panel Backs Durata Therapeutics, Inc.  (DRTX)'s Two New Anti-Infective Drugs 4/1/2014 7:38:23 AM    More...
Durata Therapeutics, Inc.  (DRTX) Reports Fourth Quarter And Full-Year 2013 Financial Results 3/14/2014 9:14:30 AM    More...
Durata Therapeutics, Inc.  (DRTX) to Announce Full Year 2013 Financial Results on March 14, 2014 3/7/2014 8:39:04 AM    More...
Durata Therapeutics, Inc.  (DRTX) To Present At Upcoming Investor Conferences 3/3/2014 9:01:09 AM    More...
Durata Therapeutics, Inc.  (DRTX) To Present At The RBC Capital Markets' Global Healthcare Conference 2/18/2014 9:07:24 AM    More...
European Medicines Agency Accepts Marketing Authorization Application For Durata Therapeutics, Inc.  (DRTX)'s Dalbavancin 12/23/2013 9:10:22 AM    More...
Durata Therapeutics, Inc.  (DRTX) Submits Marketing Authorization Application For Dalbavancin 12/3/2013 9:10:17 AM    More...
Durata Therapeutics, Inc.  (DRTX) Announces FDA's Acceptance For Priority Review Of NDA For Dalvance™ (Dalbavancin Hydrochloride) 11/27/2013 9:26:00 AM    More...
Durata Therapeutics, Inc.  (DRTX) to Present at the Jefferies 2013 Global Healthcare Conference 11/18/2013 9:18:18 AM    More...
Durata Therapeutics, Inc.  (DRTX) Reports Third Quarter 2013 Financial Results 11/6/2013 9:22:47 AM    More...
1234567